10613 Results
1

Cincinnati Business Courier: Flash therapy for cancer

November 20, 2020

UC researchers treated their first study patient this week using a new cancer therapy that takes less than one second. This clinical trial is being hosted at the Cincinnati Children's/UC Health Proton Therapy Center.

2

Channeling the immune system

November 24, 2020

University of Cincinnati researchers have discovered new clues into why some people with head and neck cancer respond to immunotherapy, while others don’t.

6

Parents: 4 signs your child is an empath

February 1, 2021

If your child is emotionally or physically sensitive, they may be an empath. A UC expert discusses qualities of an empath and offers suggestions about parenting to best support your child and their big feelings.

7

Transplant patients may not need steroid treatment in the long run

February 23, 2021

E. Steve Woodle, MD, professor of surgery at the University of Cincinnati, authored a study that shows that 15 years after transplantation no difference in kidney transplant survival or patient survival rates were found between kidney transplant patients who received long-term corticosteroids versus those who had corticosteroid eliminated early.

9

UC researcher examines genetic role in addiction

October 12, 2020

In one of the first studies of its kind, a University of Cincinnati researcher is using a grant from the Ohio attorney general’s office to research the pharmacogenomics of opioid addiction. The grant was awarded to Caroline Freiermuth, MD, associate professor in the Department of Emergency Medicine at the UC College of Medicine, the principal investigator for the study. The initial year will be supported with $1.63 million from the attorney general’s office, secured through money collected from pharmaceutical companies involved in opioid lawsuits. Pharmacogenomics, a relatively new field, is the study of how genes affect a person's response to drugs.